Literature DB >> 19153679

Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease.

Robert S Rosenson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153679     DOI: 10.1007/s10557-008-6148-1

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  21 in total

Review 1.  Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

Authors:  Robert S Rosenson; Diana M Stafforini
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids.

Authors:  Jaewoo Choi; Wujuan Zhang; Xiaodong Gu; Xi Chen; Li Hong; James M Laird; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2010-10-25       Impact factor: 3.739

Review 3.  Targeting inflammation: impact on atherothrombosis.

Authors:  Maria Giulia Marini; Chiara Sonnino; Marco Previtero; Luigi M Biasucci
Journal:  J Cardiovasc Transl Res       Date:  2013-12-11       Impact factor: 4.132

Review 4.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

5.  Anti-inflammatory and antioxidant properties of Eriobotrya japonica leaves extracts.

Authors:  Kammoun Maher; Ben Ali Yassine; Bezzine Sofiane
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

Review 6.  The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis.

Authors:  Ralph A H Stewart; Harvey D White
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 7.  Niacin: another look at an underutilized lipid-lowering medication.

Authors:  Julia C Creider; Robert A Hegele; Tisha R Joy
Journal:  Nat Rev Endocrinol       Date:  2012-02-21       Impact factor: 43.330

Review 8.  New technologies personalize diagnostics and therapeutics.

Authors:  Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

9.  Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension.

Authors:  Suzana Zorca; Lita Freeman; Mariana Hildesheim; Darlene Allen; Alan T Remaley; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

10.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.